Compare PTGX & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | NG |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.7B |
| IPO Year | 2016 | 2002 |
| Metric | PTGX | NG |
|---|---|---|
| Price | $82.25 | $10.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $99.20 | $10.83 |
| AVG Volume (30 Days) | 600.9K | ★ 5.0M |
| Earning Date | 01-01-0001 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 404.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $501.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.70 | $2.26 |
| 52 Week High | $96.54 | $12.09 |
| Indicator | PTGX | NG |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 54.26 |
| Support Level | $80.40 | $9.87 |
| Resistance Level | $83.40 | $11.92 |
| Average True Range (ATR) | 3.21 | 0.86 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 45.85 | 68.82 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.